AU1206799A - Use of macrolides for the treatment of cancer and macular degeneration - Google Patents
Use of macrolides for the treatment of cancer and macular degeneration Download PDFInfo
- Publication number
- AU1206799A AU1206799A AU12067/99A AU1206799A AU1206799A AU 1206799 A AU1206799 A AU 1206799A AU 12067/99 A AU12067/99 A AU 12067/99A AU 1206799 A AU1206799 A AU 1206799A AU 1206799 A AU1206799 A AU 1206799A
- Authority
- AU
- Australia
- Prior art keywords
- substituted
- previously defined
- heteroaryl
- aryl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96147397A | 1997-10-31 | 1997-10-31 | |
| US08961473 | 1997-10-31 | ||
| PCT/US1998/023043 WO1999022722A2 (fr) | 1997-10-31 | 1998-10-30 | Utilisation de macrolides pour le traitement du cancer et de la degenerescence maculaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1206799A true AU1206799A (en) | 1999-05-24 |
Family
ID=25504514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU12067/99A Abandoned AU1206799A (en) | 1997-10-31 | 1998-10-30 | Use of macrolides for the treatment of cancer and macular degeneration |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1027060A2 (fr) |
| JP (1) | JP2001521891A (fr) |
| KR (1) | KR20010031577A (fr) |
| CN (1) | CN1278178A (fr) |
| AR (1) | AR043071A1 (fr) |
| AU (1) | AU1206799A (fr) |
| BG (1) | BG104436A (fr) |
| BR (1) | BR9813318A (fr) |
| CA (1) | CA2307850A1 (fr) |
| HU (1) | HUP0100012A3 (fr) |
| IL (1) | IL135518A0 (fr) |
| NO (1) | NO20002189L (fr) |
| PL (1) | PL340604A1 (fr) |
| SK (1) | SK6172000A3 (fr) |
| TR (1) | TR200001147T2 (fr) |
| WO (1) | WO1999022722A2 (fr) |
| ZA (1) | ZA989885B (fr) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001248588B2 (en) | 2000-04-13 | 2006-02-02 | Biotica Technology Limited | Hybrid glycosylated products and their production and use |
| PT1539157E (pt) | 2002-09-18 | 2013-10-04 | Univ Pennsylvania | Rapamicina para utilização na inibição ou prevenção de neovascularização coroidal |
| TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| EP1608626A1 (fr) | 2003-03-28 | 2005-12-28 | Cornell Research Foundation, Inc. | Compositions de substances analogues a la migrastatine et leurs utilisations |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| CN102816194A (zh) * | 2004-02-27 | 2012-12-12 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
| CN1950388A (zh) * | 2004-02-27 | 2007-04-18 | 瑞伯-X医药品有限公司 | 大环化合物以及其制作和使用方法 |
| US8957056B2 (en) | 2004-05-25 | 2015-02-17 | Sloan-Kettering Instiute For Cancer Research | Migrastatin analogs in the treatment of cancer |
| EP1805161B1 (fr) | 2004-09-23 | 2014-05-07 | Sloan-Kettering Institute For Cancer Research | Analogues d'isomigrastatine utilises dans le traitement du cancer |
| EP1848431B1 (fr) | 2005-02-09 | 2016-02-03 | Santen Pharmaceutical Co., Ltd. | Formulations liquides pour le traitement de maladies ou affections |
| CA2615990A1 (fr) | 2005-07-18 | 2007-01-25 | Minu, L.L.C. | Neuro-protection/neuro-stimulation oculaire amelioree |
| WO2007025284A1 (fr) | 2005-08-24 | 2007-03-01 | Rib-X Pharmaceuticals, Inc. | Composes de triazole et procedes de fabrication et d'utilisation associes |
| JP2009506063A (ja) | 2005-08-24 | 2009-02-12 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | トリアゾール化合物ならびにこれを作製する方法および使用する方法 |
| WO2007092620A2 (fr) | 2006-02-09 | 2007-08-16 | Macusight, Inc. | Formulations stables et leurs procedes de preparation et d'utilisation |
| ES2563288T3 (es) | 2006-03-23 | 2016-03-14 | Santen Pharmaceutical Co., Ltd | Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular |
| CN106317146B (zh) * | 2015-06-18 | 2019-06-21 | 沈阳药科大学 | 双环克拉霉素衍生物及其作为肿瘤细胞增值抑制剂的用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6461090A (en) * | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| US5498424A (en) * | 1994-11-30 | 1996-03-12 | Klein; Ira | Method of treating obesity |
-
1998
- 1998-10-29 AR ARP980105434A patent/AR043071A1/es unknown
- 1998-10-29 ZA ZA989885A patent/ZA989885B/xx unknown
- 1998-10-30 KR KR1020007004625A patent/KR20010031577A/ko not_active Application Discontinuation
- 1998-10-30 PL PL98340604A patent/PL340604A1/xx unknown
- 1998-10-30 JP JP2000518656A patent/JP2001521891A/ja not_active Withdrawn
- 1998-10-30 HU HU0100012A patent/HUP0100012A3/hu unknown
- 1998-10-30 TR TR2000/01147T patent/TR200001147T2/xx unknown
- 1998-10-30 EP EP98955206A patent/EP1027060A2/fr not_active Withdrawn
- 1998-10-30 SK SK617-2000A patent/SK6172000A3/sk unknown
- 1998-10-30 CN CN98810825A patent/CN1278178A/zh active Pending
- 1998-10-30 IL IL13551898A patent/IL135518A0/xx unknown
- 1998-10-30 WO PCT/US1998/023043 patent/WO1999022722A2/fr not_active Application Discontinuation
- 1998-10-30 AU AU12067/99A patent/AU1206799A/en not_active Abandoned
- 1998-10-30 CA CA002307850A patent/CA2307850A1/fr not_active Abandoned
- 1998-10-30 BR BR9813318-7A patent/BR9813318A/pt not_active Application Discontinuation
-
2000
- 2000-04-27 NO NO20002189A patent/NO20002189L/no unknown
- 2000-05-15 BG BG104436A patent/BG104436A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL340604A1 (en) | 2001-02-12 |
| NO20002189L (no) | 2000-06-28 |
| HUP0100012A2 (hu) | 2001-05-28 |
| TR200001147T2 (tr) | 2000-08-21 |
| CA2307850A1 (fr) | 1999-05-14 |
| BG104436A (en) | 2000-12-29 |
| WO1999022722A3 (fr) | 1999-08-05 |
| WO1999022722A2 (fr) | 1999-05-14 |
| IL135518A0 (en) | 2001-05-20 |
| HUP0100012A3 (en) | 2003-07-28 |
| EP1027060A2 (fr) | 2000-08-16 |
| KR20010031577A (ko) | 2001-04-16 |
| JP2001521891A (ja) | 2001-11-13 |
| CN1278178A (zh) | 2000-12-27 |
| ZA989885B (en) | 1999-05-05 |
| NO20002189D0 (no) | 2000-04-27 |
| BR9813318A (pt) | 2000-08-22 |
| AR043071A1 (es) | 2005-07-20 |
| SK6172000A3 (en) | 2001-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1206799A (en) | Use of macrolides for the treatment of cancer and macular degeneration | |
| CA2309963C (fr) | Oxime de 6-o-alkyle erythromycine b | |
| JP2000500483A (ja) | ６―ｏ―メチルエリスロマイシンｄ及びその製造方法 | |
| HU211337A9 (en) | 4"-deoxyerythromycin derivatives | |
| EP1167375A1 (fr) | Derives d'erythromycine | |
| SK13162001A3 (sk) | 6-o-substituované makrolidy majúce antibakteriálnu aktivitu | |
| JPH07110874B2 (ja) | エリスロマイシンａ誘導体 | |
| US6436906B1 (en) | 9-amino-14-membered macrolides derived from leucomycins | |
| JP2003507487A (ja) | 抗菌活性を有する９ａ−アザライド類 | |
| CN113116859B (zh) | 阿奇霉素丸芯包衣制剂 | |
| US20060135494A1 (en) | Methods of treating injuries of the nervous system associated with hemorrhage | |
| CZ20001524A3 (cs) | Farmaceutický přípravek pro léčení nádorů a makulární degenerace | |
| EP1259923B1 (fr) | Agents anti-infectieux utiles contre des souches de bacteries resistant a l'action de plusieurs medicaments | |
| WO2002094183A2 (fr) | Methode de traitement d'une tumeur, utilisant des derives de fumagillol | |
| WO2023134707A1 (fr) | Méthodes de traitement d'aml-mrc et de mds | |
| WO1992019247A1 (fr) | Derives d'erythromycine | |
| WO2003039537A1 (fr) | Compositions chimioprotectrices | |
| EP1258248A2 (fr) | Traitement de tumeurs avec un dérivé de fumagillol et un autre agent antinéoplastique | |
| US20040209827A1 (en) | 11-C-substituted derivatives of clarithromycin | |
| JPH08512324A (ja) | エリスロマイシン誘導体 | |
| CN115300511A (zh) | 一种组合物的医药用途 | |
| JP2020509086A (ja) | トリアゾール含有マクロライド及びその眼科的使用 | |
| MXPA00005405A (en) | 6-o-alkyl erythromycin b oxime | |
| AU2013202332A1 (en) | Anti-bacterial applications of poly-N-acetylglucosamine nanofibers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |